Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)
However, while GLP-1 RAs did not exhibit an increased risk of acute pancreatitis, DPP-4 inhibitors demonstrated a notable risk elevation (rate ratio, 1.75) [53]
Tacrolimus maintains the balance of neutrophil extracellular traps by inducing DNA methylation of neutrophils to reduce immune rejection
The skin attributes improved at 12 weeks (as assessed by blind expert graders) for elasticity, wrinkles, and evenness in different body areas (face, hands, neck, etc.) compared with placebo measurements
Common ones include mild irritation at the injection site, fatigue, and headache
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation